I now have comprehensive data to write a complete, well-sourced answer.
Hyperechogenic Bowel Grade 1 on Anomaly Scan
What It Is
Fetal echogenic bowel (FEB) is a finding on second-trimester ultrasound (typically the 18-20 week anomaly scan) where the fetal bowel appears brighter than normal. It occurs in approximately 1% of second-trimester pregnancies.
To be considered truly echogenic, the bowel should appear "bright as bone" and persist after:
- Lowering the gain
- Disabling harmonic-enhanced imaging
- Using a lower-frequency transducer (<5 MHz)
Important: High-frequency transducers can overexaggerate the finding, leading to false positives. Grade 1 can be an artifact of technique.
Grading System (Slotnick et al.)
| Grade | Description | Echogenicity vs. Bone |
|---|
| 1 | Mildly increased echogenicity | Less echogenic than bone |
| 2 | Moderately increased echogenicity | Equal to bone |
| 3 | Pronounced increase | More echogenic than bone |
Grade 1 is the mildest form and has the most favorable prognosis. Clinical significance increases significantly with grade 2 and 3.
Causes / Differential Diagnosis
Causes range from benign to significant:
| Category | Specific Causes |
|---|
| Normal variant | Most common - aperistaltic small bowel, thick meconium; can resolve spontaneously |
| Chromosomal | Trisomy 21, trisomy 13, trisomy 18, triploidy (~10% of echogenic bowel cases) |
| Cystic Fibrosis | Meconium ileus; CF in 15-40% of meconium ileus cases; only ~2.2% of isolated echogenic bowel |
| Congenital infection (TORCH) | CMV (most common), toxoplasmosis, rubella, herpes - up to 10%; usually with cerebral calcifications, hydrops |
| Swallowed blood | From placental hemorrhage; associated with elevated maternal serum AFP |
| Bowel obstruction | Jejunal/ileal atresia, Hirschsprung disease (~2% of FEB cases) |
| FGR | Fetal growth restriction - ~20% of isolated echogenic bowel cases |
- Creasy & Resnik's Maternal-Fetal Medicine, p. 511
Associated Anomalies to Look For
- ~50% of echogenic bowel cases have other structural abnormalities and/or FGR
- Aneuploidy present in ~10%
- Increased likelihood of cardiac and renal abnormalities
- TORCH infections in up to 10% (check for cerebral calcifications, ventriculomegaly, hydrops)
- FGR in approximately 20% (OR = 2.1; 95% CI, 1.5-2.9)
Workup Recommended for Grade 1
Even for Grade 1, the following workup is typically offered, especially if isolated:
- Detailed fetal anatomy survey - rule out associated structural anomalies (cardiac, renal, brain)
- Review technique - disable harmonic imaging, reduce gain, use lower-frequency transducer to confirm it is a real finding
- Aneuploidy screening / karyotype - if not already done; offer cell-free DNA or invasive testing (amniocentesis)
- CF carrier testing - offer parental CFTR mutation analysis if not already done
- Maternal serology - CMV IgG/IgM and IgG avidity (if IgG+), toxoplasmosis serology
- Maternal serum AFP - if elevated without other explanation, associated with worse outcomes (FGR, IUFD)
- Serial growth scans - every 4 weeks to monitor for FGR and resolution of echogenicity
- Serial bowel assessment - monitor for progressive dilation or persistence
For Grade 1 specifically: If confirmed as truly grade 1 (less echogenic than bone) with no other anomalies, risk is low and many centers may simply repeat the scan in 4 weeks. Many practitioners consider isolated Grade 1 a soft marker rather than a major finding.
- Fischer's Mastery of Surgery, 8th ed., p. 8289
- StatPearls - Fetal Echogenic Bowel
Prognosis
-
~70% of isolated echogenic bowel cases resolve spontaneously on follow-up imaging
-
If no chromosomal defects, cystic fibrosis, infection, FGR, or other associated abnormalities are found - prognosis is good for normal outcome
-
Pregnancies complicated by FEB plus other anomalies, FGR, elevated AFP, or progressive worsening in grade have less favorable outcomes
-
Isolated Grade 1 with normal workup carries an excellent prognosis
-
Creasy & Resnik's Maternal-Fetal Medicine, p. 512
Practical Summary for Grade 1
| Step | Action |
|---|
| Confirm finding | Repeat with lower gain, no harmonics, lower frequency transducer |
| If confirmed | Detailed anatomy scan (cardiac, renal, brain) |
| Genetic | Offer aneuploidy screen / amniocentesis; CF carrier testing |
| Infection screen | CMV and toxoplasmosis maternal serology |
| Biochemistry | Maternal serum AFP |
| Follow-up | Serial growth scans q4 weeks; reassess bowel echogenicity |
| Counseling | Reassure that isolated Grade 1 most likely resolves; overall adverse outcome rate ~14% for all grades combined, much lower for isolated Grade 1 |
The
2023 review by Vena et al. in J Clin Ultrasound provides current evidence-based guidance on management, and
StatPearls offers a practical diagnostic flowchart.